UnitedHealth Group Incorporated [NYSE: UNH] slipped around -8.84 points on Wednesday, while shares priced at $476.24 at the close of the session, down -1.82%. The company report on January 13, 2023 that UnitedHealth Group Reports 2022 Results.
Will You Miss Out On This Growth Stock Boom?
A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.
And this is just one of our 5 Best Growth Stocks To Own For 2023.
Revenues of $324.2 Billion Grew 13% Year-Over-Year, with Double-Digit Growth at both Optum and UnitedHealthcare.
Cash Flows from Operations were $26.2 Billion or 1.3x Net Income.
UnitedHealth Group Incorporated stock is now -10.17% down from its year-to-date (YTD) trading value. UNH Stock saw the intraday high of $489.50 and lowest of $474.75 per share. The company’s 52-week high price is 558.10, which means current price is +0.31% above from all time high which was touched on 01/03/23.
Compared to the average trading volume of 3.23M shares, UNH reached a trading volume of 4340238 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about UnitedHealth Group Incorporated [UNH]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for UNH shares is $598.78 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on UNH stock is a recommendation set at 1.80. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Morgan Stanley have made an estimate for UnitedHealth Group Incorporated shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on November 23, 2022. The new note on the price target was released on November 21, 2022, representing the official price target for UnitedHealth Group Incorporated stock. Previously, the target price had yet another raise to $575, while Loop Capital analysts kept a Buy rating on UNH stock.
The Average True Range (ATR) for UnitedHealth Group Incorporated is set at 11.73, with the Price to Sales ratio for UNH stock in the period of the last 12 months amounting to 1.43. The Price to Book ratio for the last quarter was 5.96, with the Price to Cash per share for the same quarter was set at 41.06. Price to Free Cash Flow for UNH in the course of the last twelve months was 30.42.
How has UNH stock performed recently?
UnitedHealth Group Incorporated [UNH] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -2.01. With this latest performance, UNH shares dropped by -9.75% in over the last four-week period, additionally sinking by -10.72% over the last 6 months – not to mention a rise of 1.61% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for UNH stock in for the last two-week period is set at 27.27, with the RSI for the last a single of trading hit 21.61, and the three-weeks RSI is set at 32.32 for UnitedHealth Group Incorporated [UNH]. The present Moving Average for the last 50 days of trading for this stock 523.06, while it was recorded at 487.99 for the last single week of trading, and 517.90 for the last 200 days.
UnitedHealth Group Incorporated [UNH]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and UnitedHealth Group Incorporated [UNH] shares currently have an operating margin of +8.33. UnitedHealth Group Incorporated’s Net Margin is presently recorded at +6.01.
Return on Equity for this stock inclined to 25.19, with Return on Assets sitting at 8.30.
Earnings analysis for UnitedHealth Group Incorporated [UNH]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for UNH. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for UnitedHealth Group Incorporated go to 14.06%.
Insider trade positions for UnitedHealth Group Incorporated [UNH]
There are presently around $386,968 million, or 89.70% of UNH stock, in the hands of institutional investors. The top three institutional holders of UNH stocks are: VANGUARD GROUP INC with ownership of 82,969,869, which is approximately 1.038% of the company’s market cap and around 0.10% of the total institutional ownership; BLACKROCK INC., holding 71,346,624 shares of the stock with an approximate value of $33.98 billion in UNH stocks shares; and FMR LLC, currently with $23.99 billion in UNH stock with ownership of nearly 1.144% of the company’s market capitalization.
Positions in UnitedHealth Group Incorporated stocks held by institutional investors increased at the end of January and at the time of the January reporting period, where 1,419 institutional holders increased their position in UnitedHealth Group Incorporated [NYSE:UNH] by around 23,388,354 shares. Additionally, 1,284 investors decreased positions by around 26,071,186 shares, while 378 investors held positions by with 763,089,757 shares. The mentioned changes placed institutional holdings at 812,549,297 shares, according to the latest SEC report filing. UNH stock had 152 new institutional investments in for a total of 5,695,930 shares, while 82 institutional investors sold positions of 1,180,385 shares during the same period.